Top Markets
#1 Black Phoenix Black Phoenix +737.06%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.03%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +18.54%
#4 MetaDAO MetaDAO +15.56%
#5 Verus Coin Verus Coin +13.88%
#6 THORChain THORChain +10.94%
#7 The Bitcoin Bull The Bitcoin Bull +9.93%
#8 TENDIES TENDIES +9.88%
#9 PondCoin PondCoin +8.82%
#10 Akedo Akedo +8.29%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Xiamen Amoytop Biotech Co., Ltd. Xiamen Amoytop Biotech Co., Ltd.

Xiamen Amoytop Biotech Co., Ltd.

688278
Rank in Stocks #4564
Xiamen Amoytop Biotech Co., Ltd. specializes in the creation,... Xiamen Amoytop Biotech Co., Ltd. specializes in the creation, commercialization, and distribution of biopharmaceutical products within China, utilizing advanced genetic engineering techniques. Its offerings span a variety of pharmaceutical goods, including finished drug formulations, diagnostic reagents, and active pharmaceutical ingredients (APIs). The company further extends its services to include bespoke contract manufacturing. Founded in 1996, the firm is headquartered in Xiamen, China.
Share Price
$8.58
Market Cap
$3.50B
Change (1 day)
-1.35%
Change (1 year)
-25.53%
Country
CN
Trade Xiamen Amoytop Biotech Co., Ltd. (688278)

Category

Healthcare
Revenue for Xiamen Amoytop Biotech Co., Ltd. (688278)
Revenue in Aug 2026 TTM: 0
According to Xiamen Amoytop Biotech Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Xiamen Amoytop Biotech Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH